Articles published by Mirum Pharmaceuticals, Inc.
Via Business Wire
Tickers
MIRM
Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
August 09, 2024
Via Business Wire
Tickers
MIRM
Mirum Pharmaceuticals Reports Second Quarter 2024 Financial Results and Provides Business Update
August 07, 2024
Via Business Wire
Tickers
MIRM
Via Business Wire
Tickers
MIRM
Via Business Wire
Tickers
MIRM
Via Business Wire
Tickers
MIRM
Via Business Wire
Tickers
MIRM
Mirum’s Volixibat Achieves Positive Interim Analyses in VANTAGE PBC and VISTAS PSC Studies
June 17, 2024
Via Business Wire
Tickers
MIRM
Via Business Wire
Tickers
MIRM
Long-Term Data from Mirum’s LIVMARLI Studies in ALGS and PFIC Highlighted at EASL Congress
June 06, 2024
Via Business Wire
Tickers
MIRM
Via Business Wire
Tickers
MIRM
Via Business Wire
Tickers
MIRM
Via Business Wire
Tickers
MIRM
Via Business Wire
Tickers
MIRM
Via Business Wire
Tickers
MIRM
Via Business Wire
Tickers
MIRM
Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
February 09, 2024
Via Business Wire
Tickers
MIRM
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.